Anekabio LLC

Funding and NIH signals

• NIH award NIH awarded $246K (STTR Phase I 5R41NS143585-02, continuation, notice Sep 4, 2026). NIH RePORTER 5R41NS143585-02 (Sep 4, 2026)
  Evidence (1 event)

  • Sep 4, 2026 · NIH RePORTER 5R41NS143585-02
    Organization: ANEKABIO LLC; City/State: GAINESVILLE, FL; Project number: 5R41NS143585-02; Activity code: R41; Fiscal year: 2026; Award notice date: 2026-09-04; FY total cost (award amount): 245560; Administering IC: National Institute of Neurological Disorders and Stroke; Project title: Development and Validation of Efficacy Biomarkers for QTE Therapy in Friedreich's Ataxia; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals